•Novo Nordisk's STEP Young trial shows once-weekly semaglutide plus lifestyle changes lifted 40.4% of children aged 6-11 with obesity out of the obesity category after 68 weeks.
•GLP-1 prescriptions for children have surged more than 30,000% since 2019, underscoring rapid growth in pediatric use of drugs like Novo Nordisk's Wegovy.
Maya Lindstrom Rural connectivity in Africa is a solid niche business, hope the listing cleanup lets them focus on actually growing operations instead of paperwork.
Priya Raman Every time Kim unveils a new toy it's the same script - defensive posture, deterrence talk, then a bigger ask next year. Predictable escalation.